Wen-Hao Xu, Hailiang Zhang, Dingwei Ye. "Anlotinib plus everolimus as first-line treatment for advanced non–clear cell renal cell carcinoma: 1 year updated results from UC-001, a single-center, single-arm, phase II trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.4525